MPM
BRLI

Meritage Portfolio Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Meritage Portfolio Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-115,583
Closed -$2.95M – 223
2013
Q4 		$2.95M Sell
115,583
-5,217
-4% -$161K 0.37% 142
2013
Q3 		$3.61M Buy
120,800
+3,055
+3% +$85K 0.47% 110
2013
Q2 		$3.38M Buy
+117,745
New +$3.24M 0.49% 109

Other funds holding BRLI

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Meritage Portfolio Management's BRLI Position: Q1 2014 in Review

Meritage Portfolio Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2014, closing a stake of 115,583 shares — an estimated $2.95M sold.

Meritage Portfolio Management first reported a position in BRLI in Q2 2013 and held it in 3 quarters. The position peaked at $3.61M in Q3 2013. 162 funds tracked by Wall St. Rank hold BRLI as of Q1 2014.

  • Meritage Portfolio Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2014 after selling out during the quarter.
  • Meritage Portfolio Management sold 115,583 BIO-REFERENCE LABS INC-NEW- shares in Q1 2014, an estimated $2.95M.
  • Meritage Portfolio Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 3 quarters.
  • Meritage Portfolio Management's BIO-REFERENCE LABS INC-NEW- position peaked at $3.61M in Q3 2013.
  • 162 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2014.

Based on Meritage Portfolio Management's 13F filing for Q1 2014, filed 29 Apr 2014.